2025-03-13 12:41:14 ET
Cellectar Biosciences Inc. (CLRB)
Q4 2024 Earnings Conference Call
March 13, 2025 8:30 AM ET
Company Participants
Anne Marie Fields – Managing Director-Precision AQ
Jim Caruso – President and Chief Executive Officer
Chad Kolean – Chief Financial Officer
Jarrod Longcor – Chief Operating Officer
Conference Call Participants
Jonathan Aschoff – ROTH
Presentation
Operator
Ladies and gentlemen, thank you for standing by, and welcome. At this time all participants are in listen-only mode. Following the presentation, there will be a question-and-answer session. Please be advised that today's conference call may be recorded.
I would now like to hand the conference call over to Anne Marie Fields, Managing Director at Precision AQ. Please go ahead.
Anne Marie Fields
Thank you operator. Good morning, and welcome to Cellectar Biosciences' Fourth Quarter and Full Year 2024 Financial Results and Business Update Conference Call. Joining us today from Cellectar are Jim Caruso, President and CEO, who will provide an overview of the company's progress; before turning the call over to Chad Kolean, CFO, for a financial review of the quarter and the year. Following this, Jarrod Longcor, Chief Operating Officer, will give an update on the company's progress and plans for its promising clinical development pipeline of radiopharmaceuticals. Cellectar issued a press release earlier this morning detailing the content of today's call. A copy can be found on the Investor page of Cellectar's corporate website.
I want to remind callers that the information discussed on the call today is covered under the safe harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in today's press release and in our SEC filings. The content of this conference call contains time-sensitive information that's accurate only as of the date of this live broadcast, March 13, 2025....
Read the full article on Seeking Alpha
For further details see:
Cellectar Biosciences Inc. (CLRB) Q4 2024 Earnings Call Transcript
